CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 52 enrolled
Drug / intervention
Bupivacainedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00578136
NCT00578136N/ACompleted
CompareCT.gov

A Randomized-Double Blinded Trial Comparing the Analgesic Efficacy and Side Effects of Rectus Sheath Block vs. Infiltration of Surgical Site for Post Operative Pain Control After Umbilical Hernia Repair Surgery

Children's Hospital of Philadelphia·interventional·Posted Dec 20, 2007·Updated Aug 15, 2014

In Brief

A clinical study evaluating Bupivacaine for Umbilical Hernia. Completed, enrolled 52 participants across 1 site.

Detailed Summary

Umbilical hernia repair is a common painful outpatient procedure performed in children. Often analgesia for this procedure is provided by using local infiltration of the surgical site by the surgeons and perioperative opioids and NSAIDS both IV and orally. The use of opioids can cause adverse side effects which include, but are not limited to nausea, vomiting, itching, and respiratory depression, etc. The rectus sheath block can be performed in these patients to decrease their post operative pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUmbilical Hernia
CountriesUnited States
CollaboratorsChildren's Anesthesiology Associates, Ltd.

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 20, 2007
Enrollment StartNov 1, 2006
Primary CompletionDec 1, 2009
Study CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 18.5 years ago

Interventions

Bupivacainedrug

Bupivacaine, 0.25%, dose amount is weight based, injection is divided per dise with rectus sheath injection or with local infiltration of the operative area.